Safety, Tolerability, Pharmacokinetics and Early Pharmacodynamics of Single Rising Oral Doses of BI 1021958 Tablets in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2012

Conditions

Healthy

Interventions

DRUG

BI 1021958

tablet

DRUG

BI 1021958

drinking solution / tablet

DRUG

Placebo to BI 1021958

SRD part: oral administration in fasted state, FE part: oral administration in fasted state and after standard high fat breakfast

Trial Locations (1)

1310.1.1 Boehringer Ingelheim Investigational Site, Biberach